Evidence map›Paper›PMID 30274868›Full record

ArticleVaccine2018

Impact of early life exposure to ionizing radiation on influenza vaccine response in an elderly Japanese cohort.

Tomonori Hayashi, Heather E Lynch, Susan Geyer, Kengo Yoshida, Keiko Furudoi, Keiko Sasaki, Yukari Morishita, Hiroko Nagamura, Mayumi Maki, Yiqun Hu and 12 more

Open access · greenAbstract read
In one paragraph

Article in Vaccine, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.7field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Long-Term Immunological Consequences of Radiation Exposure in a Diverse Cohort of Rhesus Macaques.International journal of radiation oncology, biology, physics · 2023
    Article
  5. Review
  6. Review
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors at 7 institutions in 2 countries.

Tomonori HayashiDepartment of Molecular Biosciences, Radiation Effects Research Foundation, Hiroshima 732-0815, Japan. Electronic address: tomo@rerf.or.jp.
Heather E LynchDuke Human Vaccine Institute and Department of Medicine, Duke University School of Medicine, Durham, NC 27710, USA.
Susan GeyerHealth Informatics Institute, University of South Florida, Tampa, FL 33612, USA.
Kengo YoshidaDepartment of Molecular Biosciences, Radiation Effects Research Foundation, Hiroshima 732-0815, Japan.
Keiko FurudoiDepartment of Molecular Biosciences, Radiation Effects Research Foundation, Hiroshima 732-0815, Japan.
Keiko SasakiDepartment of Molecular Biosciences, Radiation Effects Research Foundation, Hiroshima 732-0815, Japan.
Yukari MorishitaDepartment of Molecular Biosciences, Radiation Effects Research Foundation, Hiroshima 732-0815, Japan.
Hiroko NagamuraDepartment of Molecular Biosciences, Radiation Effects Research Foundation, Hiroshima 732-0815, Japan.
Mayumi MakiDepartment of Molecular Biosciences, Radiation Effects Research Foundation, Hiroshima 732-0815, Japan.
Yiqun HuDepartment of Molecular Biosciences, Radiation Effects Research Foundation, Hiroshima 732-0815, Japan.
Ikue HayashiDivision of Basic Life Sciences, Institute of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan.
Seishi KyoizumiDepartment of Molecular Biosciences, Radiation Effects Research Foundation, Hiroshima 732-0815, Japan.
Yoichiro KusunokiDepartment of Molecular Biosciences, Radiation Effects Research Foundation, Hiroshima 732-0815, Japan.
Waka OhishiDepartment of Clinical Studies, Radiation Effects Research Foundation, Hiroshima 732-0815, Japan.
Saeko FujiwaraHiroshima Atomic Bomb Casualty Council, Hiroshima 730-0052, Japan.
Munechika MisumiDepartment of Statistics, Radiation Effects Research Foundation, Hiroshima 732-0815, Japan.
Ivo ShterevDuke Human Vaccine Institute, Duke University School of Medicine, Durham, NC 27710, USA.
Janko Nikolich-ŽugichDepartment of Immunobiology and the Arizona Center on Aging, University of Arizona College of Medicine, Tucson, AZ 85724, USA.
Donna MuraskoDepartment of Biology, College of Arts and Sciences, Drexel University, Philadelphia, PA 19104, USA.
Laura P HaleDepartment of Pathology and Duke Human Vaccine Institute, Duke University School of Medicine, Durham, NC 27710, USA.
Gregory D SempowskiDuke Human Vaccine Institute and Department of Medicine, Duke University School of Medicine, Durham, NC 27710, USA; Department of Pathology and Duke Human Vaccine Institute, Duke University School of Medicine, Durham, NC 27710, USA.
Kei NakachiDepartment of Molecular Biosciences, Radiation Effects Research Foundation, Hiroshima 732-0815, Japan.
Radiation Effects Research Foundation · JPDuke University · USDrexel University · USHiroshima Red Cross Hospital & Atomic-bomb Survivors Hospital · JPHiroshima University · JPUniversity of Arizona · USUniversity of South Florida · US

Funding

Regional Biocontainment Laboratory (RBL)UC6AI058607 · NIAID · DUKE UNIVERSITY · PI WILLIAMS, R SANDERS · 2003 to 2005
$16.3M
NIAID NIH HHS HHSN272200900059CNIAID NIH HHS UC6 AI058607
6 · The paper itself

Abstract

The objective of this study was to evaluate effects of whole body radiation exposure early in life on influenza vaccination immune responses much later in life. A total of 292 volunteers recruited from the cohort members of ongoing Adult Health Study (AHS) of Japanese atomic bomb (A-bomb) survivors completed this observational study spanning two influenza seasons (2011-2012 and 2012-2013). Peripheral blood samples were collected prior to and three weeks after vaccination. Serum hemagglutination inhibition (HAI) antibody titers were measured as well as concentrations of 25 cytokines and chemokines in culture supernatant from peripheral blood mononuclear cells, with and without in vitro stimulation with influenza vaccine. We found that influenza vaccination modestly enhanced serum HAI titers in this unique cohort of elderly subjects, with seroprotection ranging from 18 to 48% for specific antigen/season combinations. Twelve percent of subjects were seroprotected against all three vaccine antigens post-vaccination. Males were generally more likely to be seroprotected for one or more antigens post-vaccination, with no differences in vaccine responses based on age at vaccination or radiation exposure in early life. These results show that early life exposure to ionizing radiation does not prevent responses of elderly A-bomb survivors to seasonal influenza vaccine.

Indexed as

Radiation, IonizingAgedAged, 80 and overAntibodies, ViralChemokinesCytokinesFemaleHemagglutination Inhibition TestsHumansInfluenza A Virus, H1N1 SubtypeInfluenza, HumanInfluenza VaccinesMaleSex FactorsAntibodies, ViralChemokinesCytokinesInfluenza VaccinesAntibodiesAtomic-bomb radiationChemokineCytokineInfluenza vaccineRadiation

Identifiers

PMID30274868
PMCPMC8172087
OpenAlexW2893890477

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.